These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25577182)

  • 1. Substance use disorders in individuals with mild to borderline intellectual disability: current status and future directions.
    van Duijvenbode N; VanDerNagel JE; Didden R; Engels RC; Buitelaar JK; Kiewik M; de Jong CA
    Res Dev Disabil; 2015 Mar; 38():319-28. PubMed ID: 25577182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability.
    van Duijvenbode N; VanDerNagel JEL
    Eur Addict Res; 2019; 25(6):263-282. PubMed ID: 31330514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance use disorders in patients with intellectual disability admitted to psychiatric hospitalisation.
    Salavert J; Clarabuch A; Fernández-Gómez MJ; Barrau V; Giráldez MP; Borràs J
    J Intellect Disabil Res; 2018 Nov; 62(11):923-930. PubMed ID: 29961996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capture recapture estimation of the prevalence of mild intellectual disability and substance use disorder.
    VanDerNagel JE; Kiewik M; Postel MG; van Dijk M; Didden R; Buitelaar JK; de Jong CA
    Res Dev Disabil; 2014 Apr; 35(4):808-13. PubMed ID: 24530089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis.
    VanDerNagel JE; Kiewik M; van Dijk M; Didden R; Korzilius HP; van der Palen J; Buitelaar JK; Uges DR; Koster RA; de Jong CA
    Res Dev Disabil; 2017 Apr; 63():151-159. PubMed ID: 27133469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use among individuals with intellectual disabilities living independently in Flanders.
    Swerts C; Vandevelde S; VanDerNagel JE; Vanderplasschen W; Claes C; De Maeyer J
    Res Dev Disabil; 2017 Apr; 63():107-117. PubMed ID: 27061044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance use disorders in people with intellectual disability.
    Didden R; VanDerNagel J; Delforterie M; van Duijvenbode N
    Curr Opin Psychiatry; 2020 Mar; 33(2):124-129. PubMed ID: 31743126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for intellectual disabilities: a validation of the Hayes Ability Screening Index for in-patients with substance use disorder.
    Braatveit KJ; Torsheim T; Hove O
    Nord J Psychiatry; 2018 Jul; 72(5):387-392. PubMed ID: 29730963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A national profile of substance use disorder among Medicaid enrollees on the autism spectrum or with intellectual disability.
    Roux AM; Tao S; Marcus S; Lushin V; Shea LL
    Disabil Health J; 2022 Jun; 15(2S):101289. PubMed ID: 35367189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-traumatic stress disorder and substance use disorder in individuals with mild intellectual disability or borderline intellectual functioning: A review of treatment studies.
    Luteijn I; VanDerNagel JEL; van Duijvenbode N; de Haan HA; Poelen EAP; Didden R
    Res Dev Disabil; 2020 Oct; 105():103753. PubMed ID: 32763655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance abuse among individuals with intellectual disabilities.
    Carroll Chapman SL; Wu LT
    Res Dev Disabil; 2012; 33(4):1147-56. PubMed ID: 22502840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of social circumstances, substance use and substance-related harm in soon-to-be-released prisoners with and without intellectual disability.
    Bhandari A; van Dooren K; Eastgate G; Lennox N; Kinner SA
    J Intellect Disabil Res; 2015 Jun; 59(6):571-9. PubMed ID: 25171498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical illness in psychiatric inpatients: comparison of patients with and without substance use disorders.
    Frasch K; Larsen JI; Cordes J; Jacobsen B; Wallenstein Jensen SO; Lauber C; Nielsen JA; Tsuchiya KJ; Uwakwe R; Munk-Jørgensen P; Kilian R; Becker T
    Int J Soc Psychiatry; 2013 Dec; 59(8):757-64. PubMed ID: 23034284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance use disorders among personality disordered patients admitted for day hospital treatment. Implications for service developments.
    Karterud S; Arefjord N; Andresen NE; Pedersen G
    Nord J Psychiatry; 2009; 63(1):57-63. PubMed ID: 19172500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability.
    Sizoo B; van den Brink W; Koeter M; Gorissen van Eenige M; van Wijngaarden-Cremers P; van der Gaag RJ
    Drug Alcohol Depend; 2010 Feb; 107(1):44-50. PubMed ID: 19786328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use and misuse in persons with intellectual disabilities (ID): results of a survey in ID and addiction services in Flanders.
    To WT; Neirynck S; Vanderplasschen W; Vanheule S; Vandevelde S
    Res Dev Disabil; 2014 Jan; 35(1):1-9. PubMed ID: 24211791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personality dimensions and substance use in individuals with mild to borderline intellectual disabilities.
    Poelen EA; Schijven EP; Otten R; Didden R
    Res Dev Disabil; 2017 Apr; 63():142-150. PubMed ID: 27765413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment for substance-abusing people with intellectual disabilities: intervening on autonomous motivation for treatment entry.
    Frielink N; Schuengel C; Kroon A; Embregts PJ
    J Intellect Disabil Res; 2015 Dec; 59(12):1168-82. PubMed ID: 26369922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric disorders in adolescents and adults with autism and intellectual disability: a representative study in one county in Norway.
    Bakken TL; Helverschou SB; Eilertsen DE; Heggelund T; Myrbakk E; Martinsen H
    Res Dev Disabil; 2010; 31(6):1669-77. PubMed ID: 20493660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Blanco C; Alegría AA; Liu SM; Secades-Villa R; Sugaya L; Davies C; Nunes EV
    J Clin Psychiatry; 2012 Jun; 73(6):865-73. PubMed ID: 22480900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.